Bulletin of the World Health Organization

Provision of injectable contraceptives in Ethiopia through community-based reproductive health agents

Ndola Prata, Amanuel Gessessew, Alice Cartwright & Ashley Fraser

Volume 89, Number 8, August 2011, 556-564

Table 3. Care received by surveyed women due to injection of depot medroxyprogesterone acetate (DMPA) from health extension workers (HEWs) and by community-based reproductive health agents (CBRHAs), Ethiopia, 2008–2009

Characteristic 13 week questionnaire
6 month questionnaire
HEW clients (%)
CBRHA clients (%)
P
HEW clients (%)
CBRHA clients (%)
P
(n = 398) (n = 526) (n = 286) (n = 498)
Satisfaction
With DMPA 98.4 99.2 0.26 100.0 98.8 0.06
With provider 97.6 95.6 0.10 97.6 96.2 0.29
Provider services
Gave written appointment reminder 98.9 92.8 < 0.01 100.0 96.4 < 0.01
Explained potential side-effects 98.1 98.8 0.40 98.9 98.1 0.41
Discussed STI/HIV/AIDS 95.9 95.1 0.58 98.9 97.6 0.20
Explained that DMPA does not protect against HIV 97.5 97.1 0.68 98.9 99.4 0.47
Offered condoms in addition 58.3 75.8 < 0.01 72.7 80.4 0.01
Naming of side-effects from DMPA
Irregular bleeding 35.9 34.9 0.75 31.5 43.2 < 0.01
Heavy bleeding 31.7 19.9 < 0.01 33.9 31.2 0.43
Spotting 10.3 12.3 0.36 12.2 15.3 0.24
Amenorrhoea 18.2 38.7 < 0.01 20.3 41.5 < 0.01
Headache 16.4 10.3 < 0.01 16.8 10.8 0.02
Weight gain 4.5 11.7 < 0.01 9.4 21.4 < 0.01
Weight loss 1.3 1.0 0.61 0.7 2.0 0.15
Irritability 3.4 8.8 < 0.01 1.7 6.9 < 0.01
Hair loss 5.8 11.5 < 0.01 10.1 19.1 < 0.01
Naming of side-effects requiring visit to health centre
Severe headache 38.5 31.1 0.03 28.1 30.5 0.47
Very heavy bleeding 61.3 53.3 0.02 66.3 57.5 0.02
Pregnancy 21.4 16.4 0.07 31.2 32.8 0.66
Chest pain 4.3 5.8 0.32 2.1 1.6 0.65

AIDS, acquired immunodeficiency syndrome; HIV, human immunodeficiency virus; STI, sexually-transmitted infection.